ERG	O
promotes	O
T	O
-	O
acute	O
lymphoblastic	O
leukemia	O
and	O
is	O
transcriptionally	O
regulated	O
in	O
leukemic	O
cells	O
by	O
a	O
stem	O
cell	O
enhancer	O
.	O


The	O
Ets	O
-	O
related	O
gene	O
(	O
ERG	O
)	O
is	O
an	O
Ets	O
-	O
transcription	O
factor	O
required	O
for	O
normal	O
blood	O
stem	O
cell	O
development	O
.	O


ERG	O
expression	O
is	O
down	O
-	O
regulated	O
during	O
early	O
T	O
-	O
lymphopoiesis	O
but	O
maintained	O
in	O
T	O
-	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T	O
-	O
ALL	O
)	O
,	O
where	O
it	O
is	O
recognized	O
as	O
an	O
independent	O
risk	O
factor	O
for	O
adverse	O
outcome	O
.	O


However	O
,	O
it	O
is	O
unclear	O
whether	O
ERG	O
is	O
directly	O
involved	O
in	O
the	O
pathogenesis	O
of	O
T	O
-	O
ALL	O
and	O
how	O
its	O
expression	O
is	O
regulated	O
.	O


Here	O
we	O
demonstrate	O
that	O
transgenic	O
expression	O
of	O
ERG	O
causes	O
T	O
-	O
ALL	O
in	O
mice	S-SPECIES
and	O
that	O
its	O
knockdown	O
reduces	O
the	O
proliferation	O
of	O
human	S-SPECIES
MOLT4	O
T	O
-	O
ALL	O
cells	O
.	O


We	O
further	O
demonstrate	O
that	O
ERG	O
expression	O
in	O
primary	O
human	S-SPECIES
T	O
-	O
ALL	O
cells	O
is	O
mediated	O
by	O
the	O
binding	O
of	O
other	O
T	O
-	O
cell	O
oncogenes	O
SCL	O
/	O
TAL1	O
,	O
LMO2	O
,	O
and	O
LYL1	O
in	O
concert	O
with	O
ERG	O
,	O
FLI1	O
,	O
and	O
GATA3	O
to	O
the	O
ERG	O
+	O
85	O
enhancer	O
.	O


This	O
enhancer	O
is	O
not	O
active	O
in	O
normal	O
T	O
cells	O
but	O
in	O
transgenic	O
mice	S-SPECIES
targets	O
expression	O
to	O
fetal	O
liver	O
c	O
-	O
kit	O
(	O
+	O
)	O
cells	O
,	O
adult	O
bone	O
marrow	O
stem	O
/	O
progenitors	O
and	O
early	O
CD4	O
(	O
-	O
)	O
CD8	O
(	O
-	O
)	O
double	O
-	O
negative	O
thymic	O
progenitors	O
.	O


Taken	O
together	O
,	O
these	O
data	O
illustrate	O
that	O
ERG	O
promotes	O
T	O
-	O
ALL	O
and	O
that	O
failure	O
to	O
extinguish	O
activity	O
of	O
stem	O
cell	O
enhancers	O
associated	O
with	O
regulatory	O
transcription	O
factors	O
such	O
as	O
ERG	O
can	O
contribute	O
to	O
the	O
development	O
of	O
leukemia	O
.	O
